Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Lilly to acquire CrossBridge Bio for up to $300m

CrossBridge Bio develops a dual-payload ADC technology created by Kyoji Tsuchikama at the University of Texas Health Science Center.

Latest news

J&J sets the tone for Q1 earnings with strong oncology growth

The pharma giant’s CEO, Joaquin Duato, forecasts strong growth acceleration for 2026, driven in part by psoriasis pill, Icotyde.

Adcendo secures $75m in Series C funding for ADC development

Funding will enable progress on the ADCE-T02 Phase I Tiffany-01 cohort expansion in a range of solid tumours.

EU sees 2025 pharma export uptick amid competitiveness concerns

An analyst noted that this uptick may be a case of “frontloading”, meaning the EU’s 2026 export growth outlook may not be as strong.

Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma’s future into focus

As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community's attention turns to Amsterdam.

Novo Nordisk and OpenAI forge alliance to drive speedy drug development

This deal comes as the total value of AI partnerships takes a 120% uptick year-on-year between 2024 and 2025, as per GlobalData.